세계의 혈소판풍부혈장 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Platelet Rich Plasma Market is presumed to reach the market size of nearly USD 1172.97 Million by 2032 from USD 431.58 Million in 2023 with a CAGR of 11.75% under the study period 2024-2032.

Platelet-rich plasma, or PRP, is a component of human blood that contains proteins to enable blood clotting and can promote healing in a person it is derived from. When PRP is injected into the damaged tissues, it stimulates the body to grow new, healthy cells and thus promotes healing. PRP is prepared by deriving blood from the person and then passing it through two stages of centrifugation to separate PRP from red blood cells and platelet-poor plasma. PRP therapy treats patients with chronic tendinitis, osteoarthritis, tendon injuries, acute injuries, hair loss conditions, oral surgery, and plastic surgery. This therapy does not provide immediate results.

MARKET DYNAMICS

PRP therapy's various advantages like little or no pain, faster recovery, and no scar tissue over surgery are the key driving force behind this market's growth. The simplicity of this therapy will further propel its use in place of transplants. Rising incidences of sports-related injuries and increased adoption of cosmetic procedures will boost the growth of this market. PRP is becoming very popular among the geriatric community since there is absolutely no risk of infection or allergic reactions involved in the process. Growing awareness about the efficiency of platelet-rich plasma treatment in dental health will be a market booster. PRP's single major drawback is its ineffectiveness in treating areas other than the elbow, muscles, and tendons.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Platelet Rich Plasma. The growth and trends of Platelet Rich Plasma industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Platelet Rich Plasma market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Pure-PRP
• Leukocyte-rich PRP
• Pure-PRF

By Origin

• Autologous
• Allogeneic
• Homologous

By Application

• Orthopedic Surgery
• Cosmetic Surgery
• General Surgery
• Neurosurgery
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Platelet Rich Plasma market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Platelet Rich Plasma market include Zimmer Biomet Holdings Inc., AdiStem Ltd., ISTO Biologics, ThermoGenesis Holdings Inc., Stryker Corporation, Exactech Inc., EmCyte Corporation, Regen Lab, Arthrex Inc., Terumo BCT, Inc. (Terumo Corporation), DePuy Synthes Companies (Johnson & Johnson), APEX Biologix LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. PLATELET RICH PLASMA - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Origin
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data Analysis By Type
• 5.3. Pure-PRP Historic and Forecast Sales By Regions
• 5.4. Leukocyte-rich PRP Historic and Forecast Sales By Regions
• 5.5. Pure-PRF Historic and Forecast Sales By Regions

6. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY ORIGIN

• 6.1. Overview By Origin
• 6.2. Historical and Forecast Data Analysis By Origin
• 6.3. Autologous Historic and Forecast Sales By Regions
• 6.4. Allogeneic Historic and Forecast Sales By Regions
• 6.5. Homologous Historic and Forecast Sales By Regions

7. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data Analysis By Application
• 7.3. Orthopedic Surgery Historic and Forecast Sales By Regions
• 7.4. Cosmetic Surgery Historic and Forecast Sales By Regions
• 7.5. General Surgery Historic and Forecast Sales By Regions
• 7.6. Neurosurgery Historic and Forecast Sales By Regions
• 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL PLATELET RICH PLASMA MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PLATELET RICH PLASMA COMPANIES

• 9.1. Platelet Rich Plasma Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF PLATELET RICH PLASMA INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Zimmer Biomet Holdings Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. AdiStem Ltd.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. ISTO Biologics
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. ThermoGenesis Holdings Inc.
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Stryker Corporation
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Exactech Inc.
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. EmCyte Corporation
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Regen Lab
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Arthrex Inc.
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Terumo BCT Inc. (Terumo Corporation)
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. DePuy Synthes Companies (Johnson & Johnson)
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments
• 10.14. APEX Biologix LLC
  • 10.14.1 Company Overview
  • 10.14.2 Company Revenue
  • 10.14.3 Products
  • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies